In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of KitAmie S. Corbin(Oregon Health & Science University), Michael W. Deininger(Oregon Health & Science University)BloodMarch 4, 200510.1182/blood-2004-12-4771Cited by 61SaveCiteExport RISWatch citationsRelated PapersAcute dasatinib exposure commits Bcr-Abl–dependent cells to apoptosis|Blood|2009|59JAK2 ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera|Blood|2019|35Antileukemic Activity of Lysophosphatidic Acid Acyltransferase-β Inhibitor CT32228 in Chronic Myelogenous Leukemia Sensitive and Resistant to Imatinib|Clinical Cancer Research|2006|26